Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 4 | 4 |
Avg. Estimate | 0.91 | 0.94 | 3.96 | 4.49 |
Low estimate | 0.91 | 0.94 | 3.91 | 4.4 |
High estimate | 0.91 | 0.94 | 4.01 | 4.55 |
Year ago EPS | 0.9 | 0.97 | 3.86 | 3.96 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 6 | 6 |
Avg. Estimate | 8.92B | 9.46B | 39.31B | 41.93B |
Low estimate | 8.64B | 9.36B | 38.94B | 41.35B |
High estimate | 9.19B | 9.56B | 39.81B | 42.49B |
Year ago sales | 8.45B | 8.99B | 37.7B | 39.31B |
Sales growth (year/est) | 5.60% | 5.30% | 4.20% | 6.70% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|---|---|---|---|
Est. EPS | 0.82 | 0.87 | 1.14 | 0.76 |
Actual EPS | 0.9 | 0.97 | 1.28 | 0.72 |
Difference | 0.08 | 0.1 | 0.14 | -0.04 |
Surprise % | 9.80% | 11.50% | 12.30% | -5.30% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0.91 | 0.94 | 3.96 | 4.49 |
7 days ago | 0.91 | 0.94 | 3.96 | 4.49 |
30 days ago | 0 | 0 | 4.03 | 4.55 |
60 days ago | 0 | 0 | 3.99 | 4.45 |
90 days ago | 0 | 0 | 4.04 | 4.48 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 2 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 1.10% | N/A | N/A | N/A |
Next qtr. | -3.10% | N/A | N/A | N/A |
Current year | 2.60% | N/A | N/A | N/A |
Next year | 13.40% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -2.43% | N/A | N/A | N/A |